These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17464993

  • 1. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.
    Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ, Lai MY, Chen DS, Kao JH.
    Hepatology; 2007 May; 45(5):1193-8. PubMed ID: 17464993
    [Abstract] [Full Text] [Related]

  • 2. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
    Nakazawa T, Shibuya A, Takeuchi A, Shibata Y, Hidaka H, Okuwaki Y, Takada J, Tanaka Y, Watanabe M, Minamino T, Sakurai K, Koizumi W.
    J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
    [Abstract] [Full Text] [Related]

  • 3. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [Abstract] [Full Text] [Related]

  • 4. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
    Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Hsu CA, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
    [Abstract] [Full Text] [Related]

  • 5. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 6. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S.
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
    Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF.
    Hepatology; 2009 Jun; 49(6):1859-67. PubMed ID: 19378345
    [Abstract] [Full Text] [Related]

  • 8. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM, Chen YC, Tai DI, Liaw YF.
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [Abstract] [Full Text] [Related]

  • 9. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ.
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [Abstract] [Full Text] [Related]

  • 10. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M, Chauhan R, Gupta N, Hissar S, Sakhuja P, Sarin SK.
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [Abstract] [Full Text] [Related]

  • 11. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
    Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Chen DS, Kao JH.
    Antivir Ther; 2009 Apr; 14(2):203-10. PubMed ID: 19430095
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 13. [Viral factors influencing histological changes of HBeAg-negative chronic hepatitis B patients with persistently normal serum ALT levels].
    Yang YH, Xie Q, Wang H, Zhou HJ, Gui HL, Cai W, Guo SM, Yu H, Guo Q.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):434-9. PubMed ID: 19567022
    [Abstract] [Full Text] [Related]

  • 14. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS, Yang Z, Chen YY, Yang KL, Xiao YH, Wu LJ, Fan HM.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
    Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ.
    Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
    [Abstract] [Full Text] [Related]

  • 16. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
    Chen YC, Huang SF, Chu CM, Liaw YF.
    J Viral Hepat; 2012 Feb; 19(2):138-46. PubMed ID: 22239503
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [Abstract] [Full Text] [Related]

  • 18. Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia.
    Bozkaya H, Yurdaydin C, Idilman R, Tüzün A, Cinar K, Erkan O, Bozdayi AM, Erden E, Uzun Y, Cetinkaya H, Uzunalimoglu O.
    Antivir Ther; 2005 Feb; 10(2):319-25. PubMed ID: 15865226
    [Abstract] [Full Text] [Related]

  • 19. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
    Lin LY, Wong VW, Zhou HJ, Chan HY, Gui HL, Guo SM, Wang H, Huang L, Bao SS, Xie Q, Chan HL.
    J Med Virol; 2010 Sep; 82(9):1494-500. PubMed ID: 20648602
    [Abstract] [Full Text] [Related]

  • 20. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
    Yuen MF, Fung J, Seto WK, Wong DK, Yuen JC, Lai CL.
    Antivir Ther; 2009 Sep; 14(5):679-85. PubMed ID: 19704171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.